EarningsQ4 2020 Earnings Report

Rhythm Pharmaceuticals (RYTM) Q4 2020 Earnings Report

1 Followers

MX:RYTM Q4 2020 EPS Results

Actual EPS-$14.22

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$14.04

Actual Revenue$0.00

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ4 2020

Date03/01/2021

TimeBefore Open

Conference CallMonday, March 1, 2021

MX:RYTM Upcoming Earnings

Rhythm Pharmaceuticals's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-13.02 / -	-14.764	―
Aug 04, 2026	2026 (Q2)	-14.53 / -13.14	-13.504	2.67% (+0.36)
May 05, 2026	2026 (Q1)	-14.80 / -14.94	-14.584	-2.47% (-0.36)
Feb 26, 2026	2025 (Q4)	-14.49 / -13.14	-12.963	-1.39% (-0.18)
Nov 04, 2025	2025 (Q3)	-12.75 / -14.76	-13.143	-12.33% (-1.62)
Aug 05, 2025	2025 (Q2)	-12.06 / -13.50	-9.903	-36.36% (-3.60)
May 07, 2025	2025 (Q1)	-12.50 / -14.58	-42.311	65.53% (+27.73)
Feb 26, 2025	2024 (Q4)	-12.50 / -12.96	-12.603	-2.86% (-0.36)
Nov 05, 2024	2024 (Q3)	-14.49 / -13.14	-13.684	3.95% (+0.54)
Aug 06, 2024	2024 (Q2)	-12.77 / -9.90	-14.764	32.93% (+4.86)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed